Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Nanobiotix

NANO
Current price
4.36 EUR -0.17 EUR (-3.79%)
Last closed 5.07 USD
ISIN US63009J1079
Sector Healthcare
Industry Biotechnology
Exchange Euronext Paris
Capitalization 251 244 912 USD
Yield for 12 month -46.57 %
1Y
3Y
5Y
10Y
15Y
NANO
21.11.2021 - 28.11.2021

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France. Address: 60 rue de Wattignies, Paris, France, 75012

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11.34 USD

P/E ratio

Dividend Yield

Current Year

+33 183 193 USD

Last Year

+5 272 571 USD

Current Quarter

+33 183 193 USD

Last Quarter

+18 168 621 USD

Current Year

+33 183 193 USD

Last Year

+4 185 158 USD

Current Quarter

+18 168 621 USD

Last Quarter

+18 168 621 USD

Key Figures NANO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -23 686 000 USD
Operating Margin TTM 3.46 %
PE Ratio
Return On Assets TTM -19.72 %
PEG Ratio
Return On Equity TTM -198.69 %
Wall Street Target Price 11.34 USD
Revenue TTM 36 208 000 USD
Book Value -0.039 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 854.9 %
Dividend Yield
Gross Profit TTM 4 776 000 USD
Earnings per share -1.2 USD
Diluted Eps TTM -1.2 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -109.64 %

Dividend Analytics NANO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NANO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation NANO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 48.3092
Enterprise Value Revenue 6.2021
Price Sales TTM 6.9389
Enterprise Value EBITDA -2.447
Price Book MRQ 65.0172

Financials NANO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NANO

For 52 weeks

4.14 USD 9.98 USD
50 Day MA 5.25 USD
Shares Short Prior Month 51 690
200 Day MA 6.18 USD
Short Ratio 7.98
Shares Short 51 268
Short Percent 0.13 %